Episode 291: Psychedelics for Chronic Pa...

In this 318th episode I welcome Dr. Mike Hofkamp and Dr. Emily Sharpe back to the show to discuss the problem of inadequate analgesia during c-sections. We discuss the issues that came up in The Retrievals Podcast, how to prevent pain, how to treat it if it happens, and how and w ... Show More

In this 317th episode I welcome Justin Harvey, CFP, back to the show to discuss what's new in the financial world for anesthesia providers in 2025. We discuss trends in compensation, the employment outlook, the pros and cons of doing a fellowship, the most common financial mistak ... Show More

In this 316th episode I welcome Dr. Kajstura back to the show to discuss the high yield topics of airway anatomy and pharmacology. Our Sponsors:* Check out Eko: https://ekohealth.com/ACCRAC* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out F ... Show More

What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributable to psychological support? Is the psychedelic trip important for the therapeutic benefits of psychedelic treatm ... Show More

What if the key to healing depression isn’t another pill but a profound shift in consciousness? On this episode of The Dr. Hyman Show, I talk with Dr. Robin Carhart-Harris, one of the world’s leading psychedelic researchers, about how these compounds unlock plasticity in the brai ... Show More

Send us a textIn today’s episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison discuss attachment styles and how psychedelic therapy might be used to address issues related to attachment wounding. *This episode originally aired 5/16/23Learn m ... Show More

Send us a textThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DMT. ... Show More

Send us a textIn this episode of the Psychedelic Therapy Frontiers podcast Dr. Steve Thayer and Dr. Reid Robison explore how psychedelic experiences might solicit false or maladaptive beliefs. Learn more about our podcast at https://numinusnetwork.com/learn/podcast/ Learn more ab ... Show More

It's time to make psychiatry more psychedelic, says psychiatrist Benjamin Lewis. Sharing results from his clinical trial on psychedelic-assisted therapy, he highlights how group therapy paired with the safe use of psilocybin, a compound found in magic mushrooms, has the potential ... Show More

In this episode, Ben Malcolm (the Spirit Pharmacist) brings us into the intersection of psychedelics and pharmacology. We discuss practical considerations, such as guidelines for safely tapering off SSRIs before embarking on a psychedelic experience and navigating contraindicatio ... Show More

In this episode, we discuss our article of the week from JAMA Network Open which is entitled “Patient complexity, social factors, and hospitalization outcomes at academic and community hospitals.” Then, we discuss the positive relief on pain and anxiety that immersive imagery and ... Show More

In this episode, we explore the potential of N-acetylcysteine (NAC) in treating mood disorders. We discuss its mechanism of action, clinical evidence for its use in depression and bipolar disorder, and its possible benefits for both adults and children. Could this natural compoun ... Show More

In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-wor ... Show More